RE:RE:RE:New Corporate UpdateWe have been holding too long. It would be nice if it's more than just a pattern this time. Unless they announce the phase 1 clinicals starting for PMN310, they have no reason to do another PP as they wouldn't have spent all the $7 million USD ($8.8 million CAD) in the past few months. I did see the serology test revenue estimated time line has been pushed to later in the year, but i am not counting on it as we might be too late. Only way that could drive a lot of revenue is if the government uses it and mandates PMN serology test over others and there's a good chance they might do it as they awarded a lot of money last year to PMN for the antibody research.
M101 wrote: It's just a trading pattern,
demand is up while pp sellers are not so we get a couple of high closes producing a feedback loop.